Population pharmacokinetics/pharmacodynamics analysis confirming biosimilarity of SB16 to reference denosumab
BackgroundThis analysis aims to evaluate the population pharmacokinetics (PK) and pharmacodynamics (PD) of denosumab and applied a population PK/PD approach to assess the biosimilarity of SB16 in comparison to reference product, denosumab (DEN).MethodsPooled serum concentrations data for SB16 and DE...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2025-08-01
|
| Schriftenreihe: | Frontiers in Pharmacology |
| Schlagworte: | |
| Online-Zugang: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1631034/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|